How were (BXLT)'s earnings last quarter?

(BXLT) (NYSE:BXLT) posted its quarterly earnings data on Thursday, April, 28th. The biotechnology company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.01. The biotechnology company had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.47 billion. The business's revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.40 earnings per share.

Is (BXLT) a good dividend stock?

(BXLT) (NYSE:BXLT) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 9.43%. This payout ratio is at a healthy, sustainable level, below 75%. Read our dividend analysis for BXLT .

What other stocks do shareholders of (BXLT) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (BXLT) investors own include Baxter International (BAX) , Hawkins (HWKN) , AbbVie (ABBV) , Allergan (AGN) , Vertex Pharmaceuticals (VRTX) , Alibaba Group (BABA) , Bank of America (BAC) , Edwards Lifesciences (EW) , Gilead Sciences (GILD) and Micron Technology (MU) .

NYSE:BXLT

(BXLT) (BXLT) Stock Price, News & Analysis

→ Trump’s “Tax Free” Retirement Strategy (From Gold Safe Exchange) (Ad)

Free BXLT Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Today's Range: $46.02
▼
$46.02
50-Day Range: N/A
52-Week Range: $29.83
▼
$46.52

Volume: N/A
Average Volume: 12.66 million shs
Market Capitalization: N/A

P/E Ratio: 15.49
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get (BXLT) alerts:

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

About (BXLT) Stock (NYSE:BXLT)

Baxalta Incorporated (Baxalta) is a biopharmaceutical company with a portfolio of differentiated therapies that seek to address medical needs across various disease areas, including hemophilia, immunology and oncology. Baxalta's categories of products include Hemophilia products, such as Advate, Adynovate, Recombinate, Hemofil M, Immunate, Immunine, Rixubis and Prothromplex Total; Inhibitor Therapies products, including FEIBA and OBIZUR; Immunoglobulin Therapies products, which include GAMMAGARD LIQUID/KIOVIG, HYQVIA, GAMMAGARD S/D and SUBCUVIA; BioTherapeutics products, including FLEXBUMIN, BUMINATE, ARALAST NP, GLASSIA NP and CEPROTIN, and Oncology product, such as ONCASPAR. Baxalta Company develops, manufactures and markets a portfolio of treatments for hemophilia and other bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns and shock, and other chronic and acute medical conditions, as well as oncology treatments for acute lymphoblastic leukemia.

Ad The Bull Report

Healthcare Takes A Big Step Forward With The Help Of AI

The average doctor can diagnose an illness correctly 50-90% of the time. But one innovative company's medical AI gets it right 92%+.

Click here to see why this small company is trusted by the Mayo Clinic

BXLT Stock News Headlines

April 5, 2024 | morningstar.com

AnyMind Group Inc 5027

February 25, 2024 | morningstar.com

IDICO Corp JSC Ordinary Shares IDC

April 16, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

February 20, 2024 | morningstar.com

Hana Financial Group Inc 086790

September 15, 2023 | thestreet.com

Baxter Int'l. (BAX) Stock Price Target Lowered by Analysts

August 25, 2023 | thestreet.com

Allergan Could Buy These Drug Companies Now That the Pfizer Merger Is Scuttled

July 25, 2023 | thestreet.com

4 Smart Stocks to Add to Your Portfolio in 2016, from Recon’s Kevin Kelly

May 31, 2023 | msn.com

Fed Beige Book: Pace of hiring and pricing is slowing

April 16, 2024 | Paradigm Press (Ad)

Bitcoin Rockets To Record High But Buy THIS Instead

Recently, Bitcoin smashed through its previous record high to hit $72,720. It’s made many, many people very rich. But one cryptocurrency expert and investing millionaire is declaring…

May 31, 2023 | msn.com

Adidas' remaining Yeezy sneakers go on sale

March 29, 2023 | msn.com

Suburban businesses accuse convicted credit card fraudster John Hancock of more crimes

February 17, 2023 | msn.com

Chevron to send over 100,000 bpd of Venezuelan oil to U.S. this month

December 23, 2022 | msn.com

New Vernon, B.C. supportive housing building set to open

December 23, 2022 | msn.com

1 victim identified in double shooting in College Hill, police say

November 16, 2022 | msn.com

Crews continue working to restore water service in Zavalla

October 4, 2022 | msn.com

Morgan City man arrested for stealing car, multiple active warrants found

September 8, 2022 | msn.com

Evo Morales accuses Bolivian ministers of executing «a black plan» against him

August 23, 2022 | thestreet.com

PayPal Is Cramer and Mohr’s Newest Addition to the AAP Portfolio

August 12, 2022 | msn.com

Video Explains How the Earth Is Spinning Faster Lately And Viewers Have Comments

March 1, 2022 | thestreet.com

4 Pharmaceutical Stocks to Buy in Wake of Shire-Baxalta Bid

See More Headlines

Receive BXLT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (BXLT) and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 4/28/2016
Today: 4/16/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: N/A
Industry: N/A
Sub-Industry: N/A
Current Symbol: NYSE:BXLT
CUSIP: N/A
CIK: 1620546
Web: www.baxalta.com
Phone: +1-224-9402000
Fax: N/A
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: 15.49
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: N/A

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

BXLT Stock Analysis - Frequently Asked Questions

How were (BXLT)'s earnings last quarter?: (BXLT) (NYSE:BXLT) posted its quarterly earnings data on Thursday, April, 28th. The biotechnology company reported $0.47 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.01. The biotechnology company had revenue of $1.50 billion for the quarter, compared to analysts' expectations of $1.47 billion. The business's revenue for the quarter was up 10.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.40 earnings per share.
Is (BXLT) a good dividend stock?: (BXLT) (NYSE:BXLT) pays an annual dividend of $0.28 per share and currently has a dividend yield of 0.00%. The dividend payout ratio is 9.43%. This payout ratio is at a healthy, sustainable level, below 75%.
Read our dividend analysis for BXLT.
What other stocks do shareholders of (BXLT) own?: Based on aggregate information from My MarketBeat watchlists, some companies that other (BXLT) investors own include Baxter International (BAX), Hawkins (HWKN), AbbVie (ABBV), Allergan (AGN), Vertex Pharmaceuticals (VRTX), Alibaba Group (BABA), Bank of America (BAC), Edwards Lifesciences (EW), Gilead Sciences (GILD) and Micron Technology (MU).

This page (NYSE:BXLT) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

(BXLT) (BXLT) Stock Price, News & Analysis

About (BXLT) Stock (NYSE:BXLT)

BXLT Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

BXLT Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info